India's Tagros has acquired Bayer AG's Flubendiamide business assets, gaining access to over 25 countries. This strengthens Tagros' position in the Diamide insecticide segment, supporting Indian and ...

Bayer AG’s pharmaceuticals unit is on track for a return to growth as new drugs for cancer and kidney disease offset sales lost to patent expirations.

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

The US Supreme Court agreed on Friday to hear Bayer’s bid to sharply limit lawsuits claiming that the company’s Roundup ...

By Patricia Weiss BERLIN, Jan 13 (Reuters) - The pharmaceuticals and agriculture group Bayer aims to return its pharmaceuticals business to mid-single-digit percentage growth by no later than 2027 and ...

As Northern European growers face plant disease and tightening regulations, Bayer launches a new strawberry to meet those ...

Bayer said on Tuesday that weak agricultural markets mean its earnings are likely to fall further next year, sparking a sharp fall in the German company’s shares and piling pressure on its CEO to ...

Bayer AG forecast a third straight year of falling profit as the German company struggles with mass litigation in the US, slumping prices for agriculture products and fresh competition for one of its ...

Bayer and university researchers summarized several years of data, concluding that short-stature corn systems reduced carbon intensity for growing corn by 13%. The same study concluded that root ...